EBITDA spoločnosti Reliv` International
Aká je hodnota metriky EBITDA spoločnosti Reliv` International?
Hodnota metriky EBITDA spoločnosti Reliv` International, Inc. je N/A
Aká je definícia metriky EBITDA?
EBITDA je zisk pred odpočítaním úrokov, daní, odpisov, a amortizácie reprezentujúci operačnú výkonnosť spoločnosti.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
Čomu sa venuje spoločnosť Reliv` International?
reliv international, inc. or reliv, is a worldwide marketer and manufacturer of nutritional supplements. the company is based near st. louis in chesterfield, mo., and its products are sold in the united states, canada, mexico, united kingdom, ireland, germany, australia, new zealand, philippines, malaysia, singapore, austria, the netherlands and indonesia. products are sold through a direct selling format, with a network over 40,000 distributors and preferred customers globally. reliv has a rating of ‘a’ by the better business bureau of the united states. reliv international, inc. is the corporation that develops, manufactures and markets reliv products. reliv independent distributors are independent contractors of reliv international, inc.